BioCryst Pharmaceuticals
BCRX
#4498
Rank
NZ$2.83 B
Marketcap
$13.56
Share price
2.02%
Change (1 day)
83.78%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -$2.02

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.09. In 2022 the company made an earnings per share (EPS) of -$2.22 a decrease over its 2021 EPS that were of -$1.72.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.02-8.97%
2022-$2.2229.13%
2021-$1.72-4.63%
2020-$1.8010.2%
2019-$1.640%
2018-$1.6425.64%
2017-$1.304%
2016-$1.2527.12%
2015-$0.99-13.24%
2014-$1.1423.64%
2013-$0.92-30.38%
2012-$1.32-37.3%
2011-$2.1065.79%
2010-$1.27117.14%
2009-$0.58-46.15%
2008-$1.09-26.97%
2007-$1.49-40.67%
2006-$2.5048.51%
2005-$1.691%
2004-$1.6738.89%
2003-$1.20-25%
2002-$1.60231.03%
2001-$0.48-56.72%
2000-$1.1291.43%
1999-$0.582.94%
1998-$0.57-55.84%
1997-$1.2911.59%
1996-$1.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.49-267.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.07 526.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.99-52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-$12.00 475.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.33-451.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.01 92.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.84-380.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$20.17 866.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.29-38.40%๐Ÿ‡บ๐Ÿ‡ธ USA